S'abonner

Sebaceous carcinoma: evidence-based clinical practice guidelines - 03/12/19

Doi : 10.1016/S1470-2045(19)30673-4 
Joshua L Owen, MD a, , Nour Kibbi, MD f, , Brandon Worley, MD a, g, , Ryan C Kelm, MD a, Jordan V Wang, MD j, Christopher A Barker, MD l, Ramona Behshad, MD m, Christopher K Bichakjian, ProfMD n, Diana Bolotin, MD p, Jeremy S Bordeaux, ProfMD q, Scott H Bradshaw, MD h, Todd V Cartee, MD r, Sunandana Chandra, MD b, Nancy L Cho, MD s, Jennifer N Choi, MD a, M Laurin Council, MD t, Hakan Demirci, MD o, Daniel B Eisen, ProfMD u, Bita Esmaeli, ProfMD v, Nicholas Golda, MD z, Conway C Huang, MD aa, Sherrif F Ibrahim, MD ab, S Brian Jiang, ProfMD ac, John Kim, ProfMD c, Timothy M Kuzel, ProfMD ad, Stephen Y Lai, ProfMD w, Naomi Lawrence, ProfMD ae, Erica H Lee, MD af, Justin J Leitenberger, MD ag, Ian A Maher, MD ah, Margaret W Mann, MD ai, Kira Minkis, MD aj, Bharat B Mittal, ProfMD d, Kishwer S Nehal, ProfMD af, Isaac M Neuhaus, MD ak, David M Ozog, MD al, Brian Petersen, MD am, Veronica Rotemberg, MD af, Sandeep Samant, ProfMD e, Faramarz H Samie, MD an, Sabah Servaes, MD ao, Carol L Shields, ProfMD k, Thuzar M Shin, MD ap, Joseph F Sobanko, MD ap, Ally-Khan Somani, MD aq, William G Stebbins, MD ar, J Regan Thomas, ProfMD e, Valencia D Thomas, MD y, David T Tse, ProfMD as, Abigail H Waldman, MD at, Michael K Wong, ProfMD x, Y Gloria Xu, MD au, Siegrid S Yu, MD ak, Nathalie C Zeitouni, ProfMD av, Timothy Ramsay, PhD i, Kelly A Reynolds, BA a, Emily Poon, PhD a, Murad Alam, ProfMD a,
a Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA 
b Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA 
c Department of Plastic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA 
d Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA 
e Department of Otolaryngology—Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA 
f Department of Dermatology, Yale School of Medicine, New Haven, CT, USA 
g Division of Dermatology, The Ottawa Hospital, Ottawa, ON, Canada 
h Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada 
i The Ottawa Health Research Institute, The Ottawa Hospital, Ottawa, ON, Canada 
j Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, USA 
k Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA 
l Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 
m Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, MO, USA 
n Department of Dermatology, University of Michigan, Ann Arbor, MI, USA 
o Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI, USA 
p Section of Dermatology, The University of Chicago, Chicago, IL, USA 
q Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA 
r Division of Dermatology, Pennsylvania State University, Hershey, PA, USA 
s Department of Surgery, Brigham and Women’s Hospital, Harvard University, Boston, MA, USA 
t Division of Dermatology, Center for Dermatologic and Cosmetic Surgery, Washington University in Saint Louis, Saint Louis, MO, USA 
u Department of Dermatology, University of California Davis, Sacramento, CA, USA 
v Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
w Departments of Head and Neck Surgery and Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
x Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
y Dermatology and Dermatopathology, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
z Department of Dermatology, University of Missouri School of Medicine, Columbia, MO, USA 
aa Department of Dermatology, University of Alabama, Birmingham, AL, USA 
ab Department of Dermatology, University of Rochester, Rochester, NY, USA 
ac Department of Dermatology, University of California San Diego, San Diego, CA, USA 
ad Division of Hematology, Oncology and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA 
ae Department of Dermatology, Cooper Hospital, Rowan University, Camden, NJ, USA 
af Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA 
ag Department of Dermatology, Oregon Health and Science University, Portland, OR, USA 
ah Department of Dermatology, University of Minnesota, Minneapolis, MN, USA 
ai Department of Dermatology, University Hospital, Cleveland, OH, USA 
aj Department of Dermatology, Weill-Cornell Medical College, New York, NY, USA 
ak Department of Dermatology, University of California at San Francisco, San Francisco, CA, USA 
al Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA 
am Department of Dermatology, Colorado Permanente Medical Group, Denver, CO, USA 
an Department of Dermatology, Columbia University Medical Center, New York, NY, USA 
ao Department of Radiology, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA 
ap Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA 
aq Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA 
ar Department of Dermatology, Vanderbilt University Medical Center, Nashville, TN, USA 
as Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA 
at Brigham and Women’s Hospital Department of Dermatology, Harvard Medical School, Boston, MA, USA 
au Department of Dermatology, University of Wisconsin-Madison, Madison, WI, USA 
av Department of Dermatology, University of Arizona, Phoenix, AZ, USA 

* Correspondence to: Dr Murad Alam, Department of Dermatology, Northwestern University, 676 N St Clair, Suite 1600, Chicago, IL 60611, USA Department of Dermatology Northwestern University 676 N St Clair Suite 1600 Chicago IL 60611 USA

Summary

Sebaceous carcinoma usually occurs in adults older than 60 years, on the eyelid, head and neck, and trunk. In this Review, we present clinical care recommendations for sebaceous carcinoma, which were developed as a result of an expert panel evaluation of the findings of a systematic review. Key conclusions were drawn and recommendations made for diagnosis, first-line treatment, radiotherapy, and post-treatment care. For diagnosis, we concluded that deep biopsy is often required; furthermore, differential diagnoses that mimic the condition can be excluded with special histological stains. For treatment, the recommended first-line therapy is surgical removal, followed by margin assessment of the peripheral and deep tissue edges; conjunctival mapping biopsies can facilitate surgical planning. Radiotherapy can be considered for cases with nerve or lymph node involvement, and as the primary treatment in patients who are ineligible for surgery. Post-treatment clinical examination should occur every 6 months for at least 3 years. No specific systemic therapies for advanced disease can be recommended, but targeted therapies and immunotherapies are being developed.

Le texte complet de cet article est disponible en PDF.

Plan


© 2019  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 20 - N° 12

P. e699-e714 - décembre 2019 Retour au numéro
Article précédent Article précédent
  • Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review
  • Justyna Mierzynska, Claire Piccinin, Madeline Pe, Francesca Martinelli, Carolyn Gotay, Corneel Coens, Murielle Mauer, Alexander Eggermont, Mogens Groenvold, Kristin Bjordal, Jaap Reijneveld, Galina Velikova, Andrew Bottomley
| Article suivant Article suivant
  • EANO–EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma
  • Enrico Franceschi, Silvia Hofer, Alba A Brandes, Didier Frappaz, Rolf-Dieter Kortmann, Jacoline Bromberg, Volodia Dangouloff-Ros, Nathalie Boddaert, Elke Hattingen, Benedikt Wiestler, Steven C Clifford, Dominique Figarella-Branger, Felice Giangaspero, Christine Haberler, Torsten Pietsch, Kristian W Pajtler, Stefan M Pfister, Raphael Guzman, Walter Stummer, Stephanie E Combs, Clemens Seidel, Dagmar Beier, Martin G McCabe, Michael Grotzer, Florence Laigle-Donadey, Ana S Guerreiro Stücklin, Ahmed Idbaih, Matthias Preusser, Martin van den Bent, Michael Weller, Peter Hau

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.